Speech & ABA Therapy Franchising vs ACASA Senior Care

ACASA Senior Care is the stronger near-term target on TAM and timing. With seven franchised units to Speech & ABA’s four, you’re looking at a 75% larger installed base to sell into today—and that base is growing fast at 40% unit growth year-over-year. More units now plus rapid expansion means a compounding pipeline: initial deployments turn into follow-on rollouts as new locations open. The 2025 FDD filing also signals an active, compliant franchisor that’s still investing in its system, which correlates with higher technology adoption rates.

The terrain advantage tilts further toward ACASA. Its lower investment range ($83K–$134K) means franchisees carry less debt load and have more free cash flow for software early in their lifecycle. Speech & ABA’s range stretches to $669K, which often forces operators to defer non-clinical tech spend. Both brands use an approved-supplier model, so you’ll need to win franchisor endorsement either way, but ACASA’s $6.9M AUV gives individual operators serious budget capacity—your POS and back-office bundle can land at a price point that’s material to you without being a rounding error to them.

The meaningful tradeoff is that Speech & ABA’s higher per-unit investment and clinical focus might make them stickier, higher-ACV accounts once you’re in, but right now that’s a longer, harder sale against a smaller, slower-growing base. You’re better off capturing velocity and reference accounts inside ACASA’s expanding system while the growth curve is steep.

Verdict: ACASA Senior Care wins on unit count, growth rate, operator budget headroom, and franchisor compliance timing—sell there first.